Composition   Each chewable tablet contains the following active ingredients:

Aluminum hydroxide .................. 160 mg

Magnesium carbonate ................ 105 mg

and the following inactive ingredients: alginic acid, calcium stearate, flavor, sodium bicarbonate, and sucrose. May contain stearic acid. Contains sorbitol or mannitol. May contain starch.

Actions:   Gavison's unique antacid foam barrier neutralizes stomach acid.

  For the relief of heartburn, sour stomach, acid indigestion and upset stomach associated with these conditions.

Directions:   Chew 2 to 4 tablets four times a day or as directed by a physician. Tablets should be taken after meals and at bedtime or as needed. For best results follow by a half glass of water or other liquid. DO NOT SWALLOW WHOLE.

:   Do not take more than 16 tablets in a 24-hour period or 16 tablets daily for more than 2 weeks, except under the advice and supervision of a physician. Do not use this product except under the advice and supervision of a physician if you are on a sodium-restricted diet. Each Extra Strength Gaviscon tablet contains approximately 1.3 mEq sodium.

Drug Interaction Precaution:   Antacids may interact with certain prescription drugs. If you are presently taking a prescription drug, do not take this product without checking with your physician or other health professional.

Store at a controlled room temperature in a dry place.

Keep this and all drugs out of the reach of children. In case of accidental overdose, seek professional assistance or contact a poison control center immediately.

How Supplied:    Bottles of 100 tablets and in foil-wrapped 2s in boxes of 6 and 30 tablets.


NOTE: These photos can be used only for identification by shape, color, and imprint. They do not depict actual or relative size.

The product samples shown here have been supplied by the manufacturer and reproduced in full color by PDR as a quick-reference identification aid. While every effort has been made to assure accurate reproduction, please remember that any visual identification should be considered preliminary. In cases of poisoning or suspected overdosage, the drug' identity should be verified by chemical analysis.